Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

NCT01222338 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

123

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: V-5 immunitor

Sponsor

Lisichansk Regional Tuberculosis Dispensary

Collaborators

[object Object]
[object Object]